Sartorius AG
SARTFOTCHealthcare● Active
$227.00
+$9.35(+4.30%)
Market Cap$15.7B
P/E Ratio—
52W High$227
52W Low$181.58
Sartorius AG (SARTF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
SARTF · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: Apr 23, 2026EPS Actual
$1.39
Est. $1.48 · -6.1%
Revenue
$1.04B
Est. $1.04B · +0.1%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
Apr 23, 2026
After Market Close
▼ Miss EPS
SARTF reports quarterly as a OTC-listed Medical - Instruments & Supplies company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Jul 23, 2026 | $1.57 | — | — | — | $1.07B | — |
| ▼ Q2 FY2026 | Apr 23, 2026 | $1.48 | $1.39 | -6.1% | $1.04B | $1.04B | +0.1% |
| ▼ Q1 FY2026 | Feb 16, 2026 | $1.54 | $1.48 | -3.9% | $1.09B | $1.08B | +1.1% |
| — Q4 FY2025 | Oct 16, 2025 | $1.25 | $1.26 | +0.8% | $1.16B | $1.09B | +6.4% |
| ▼ Q3 FY2025 | Jul 22, 2025 | $1.53 | $1.38 | -9.8% | $1.04B | $1.05B | -0.4% |
| — Q2 FY2025 | Apr 16, 2025 | $1.28 | $1.28 | +0.0% | $0.97B | $1.03B | -6.2% |
| ▼ Q1 FY2025 | Feb 17, 2025 | $1.17 | $1.11 | -5.1% | $0.94B | $0.87B | +7.7% |
| — Q4 FY2024 | Oct 17, 2024 | $0.96 | $0.96 | +0.4% | $0.87B | $0.91B | -4.1% |
Q3 FY2026
Jul 23, 2026
EPS Actual
—
EPS Est.
$1.57
EPS Surpr.
—
Revenue
—
Q2 FY2026
Apr 23, 2026Miss
EPS Actual
$1.39
EPS Est.
$1.48
EPS Surpr.
-6.1%
Revenue
$1.04B
Q1 FY2026
Feb 16, 2026Miss
EPS Actual
$1.48
EPS Est.
$1.54
EPS Surpr.
-3.9%
Revenue
$1.09B
Q4 FY2025
Oct 16, 2025
EPS Actual
$1.26
EPS Est.
$1.25
EPS Surpr.
+0.8%
Revenue
$1.16B
Q3 FY2025
Jul 22, 2025Miss
EPS Actual
$1.38
EPS Est.
$1.53
EPS Surpr.
-9.8%
Revenue
$1.04B
Q2 FY2025
Apr 16, 2025
EPS Actual
$1.28
EPS Est.
$1.28
EPS Surpr.
+0.0%
Revenue
$0.97B
Q1 FY2025
Feb 17, 2025Miss
EPS Actual
$1.11
EPS Est.
$1.17
EPS Surpr.
-5.1%
Revenue
$0.94B
Q4 FY2024
Oct 17, 2024
EPS Actual
$0.96
EPS Est.
$0.96
EPS Surpr.
+0.4%
Revenue
$0.87B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $1.78 | $1.82 | $1.86 | 1 |
| Q3 FY2027 | $1.51 | $1.54 | $1.58 | 1 |
| Q2 FY2027 | $1.53 | $1.56 | $1.60 | 1 |
| Q1 FY2027 | $1.31 | $1.33 | $1.37 | 1 |
| Q4 FY2026 | $1.51 | $1.54 | $1.58 | 1 |
| Q3 FY2026 | $1.30 | $1.32 | $1.36 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $1.1B | $1.1B | $1.1B | 3 |
| Q3 FY2027 | $1.0B | $1.0B | $1.0B | 3 |
| Q2 FY2027 | $1.0B | $1.0B | $1.0B | 3 |
| Q1 FY2027 | $1.0B | $1.0B | $1.0B | 4 |
| Q4 FY2026 | $1.0B | $1.0B | $1.0B | 4 |
| Q3 FY2026 | $0.9B | $0.9B | $0.9B | 7 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | Apr 23, 2026 | -6.1% | $226.33 | $226.33 | +0.00% |
| ▼ Q1 FY2026 | Feb 16, 2026 | -3.9% | $226.33 | $226.33 | +0.00% |
| ▲ Q4 FY2025 | Oct 16, 2025 | +0.8% | $206.85 | $211.46 | +2.23% |
| ▼ Q3 FY2025 | Jul 22, 2025 | -9.8% | $200.20 | $200.20 | +0.00% |
| ▲ Q2 FY2025 | Apr 16, 2025 | +0.0% | $165.49 | $165.49 | +0.00% |
| ▼ Q1 FY2025 | Feb 17, 2025 | -5.1% | $205.97 | $205.97 | +0.00% |
| ▲ Q4 FY2024 | Oct 17, 2024 | +0.4% | $197.24 | $197.24 | +0.00% |
| ▲ Q3 FY2024 | Jul 18, 2024 | +17.1% | $213.42 | $214.43 | +0.47% |
Q2 FY2026+0.00%
Report Date
Apr 23, 2026
EPS Beat/Miss
-6.1%
Price Before
$226.33
Price After
$226.33
Q1 FY2026+0.00%
Report Date
Feb 16, 2026
EPS Beat/Miss
-3.9%
Price Before
$226.33
Price After
$226.33
Q4 FY2025+2.23%
Report Date
Oct 16, 2025
EPS Beat/Miss
+0.8%
Price Before
$206.85
Price After
$211.46
Q3 FY2025+0.00%
Report Date
Jul 22, 2025
EPS Beat/Miss
-9.8%
Price Before
$200.20
Price After
$200.20
Q2 FY2025+0.00%
Report Date
Apr 16, 2025
EPS Beat/Miss
+0.0%
Price Before
$165.49
Price After
$165.49
Q1 FY2025+0.00%
Report Date
Feb 17, 2025
EPS Beat/Miss
-5.1%
Price Before
$205.97
Price After
$205.97
Q4 FY2024+0.00%
Report Date
Oct 17, 2024
EPS Beat/Miss
+0.4%
Price Before
$197.24
Price After
$197.24
Q3 FY2024+0.47%
Report Date
Jul 18, 2024
EPS Beat/Miss
+17.1%
Price Before
$213.42
Price After
$214.43
Avg Beat Reaction+0.68%
Avg Miss Reaction+0.00%
Beat Rate4 / 8 quarters
Largest Move+2.23% (Q4 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: SARTF ends December
Sartorius AG (SARTF) most recently reported earnings on April 23, 2026 for Q2 FY2026, posting EPS of $1.39 — missing the analyst consensus of $1.48 by -6.1%. The next SARTF earnings date is expected around September 1, 2026.
Each quarter, investors track SARTF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. SARTF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
SARTF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
SARTF earnings · 5 questionsSartorius AG's next earnings report is expected around September 1, 2026. SARTF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; SARTF historically reports after market close (AMC).
SARTF earnings datewhen is SARTF earningsSARTF next earnings datewhen does SARTF report earningsSARTF earnings calendar
▸ Source: FMP · Sartorius AG SEC filings · US GAAP · Sartorius AG SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026